GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BNC Korea Co Ltd (XKRX:256840) » Definitions » Selling and Marketing Expense

BNC Korea Co (XKRX:256840) Selling and Marketing Expense : ₩4,752 Mil (TTM As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is BNC Korea Co Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. BNC Korea Co's Selling and Marketing Expense for the three months ended in Sep. 2024 was ₩1,808 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Sep. 2024 was ₩4,752 Mil.

BNC Korea Co Selling and Marketing Expense Historical Data

The historical data trend for BNC Korea Co's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BNC Korea Co Selling and Marketing Expense Chart

BNC Korea Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial 1,225.03 1,089.86 4,576.52 7,765.90 4,565.29

BNC Korea Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 837.43 913.39 1,069.29 961.42 1,807.69

BNC Korea Co Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,752 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BNC Korea Co Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of BNC Korea Co's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

BNC Korea Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BNC Korea Co Ltd (XKRX:256840) » Definitions » Selling and Marketing Expense
Comparable Companies
XKRX:016580 XKRX:271980 XKRX:003060 XKRX:220100 XKRX:234080 XKRX:293480 XKRX:096760 XKRX:032300 XKRX:001630 XKRX:011040 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
62 Seongseogongdan-ro 11-gil, Dalseo-gu, No 405, Structure 1, Daegu Techno Park Venture Factory, Daegu, KOR, 42713
Website
http://www.bnckorea.co.kr
BNC Korea Co Ltd is a Korean healthcare company. The company is engaged in manufacturing medicinal chemicals, antibiotics, and biological products. IIts product offering includes cutegel, cutegel lidocaine, FLORE lidocaine, ChungA-an, cutegel-M under the HA filler product line. While it also offers Skin booster filler, hibarry, gentaQ, and I.st products.

BNC Korea Co Headlines

No Headlines